These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2520968)

  • 21. Vasodilator properties of nitroglycerin and isosorbide dinitrate during cardiopulmonary bypass.
    Muikku O; Hynynen M; Salmenperä M; Heinonen J
    Br J Anaesth; 1992 Apr; 68(4):376-80. PubMed ID: 1642915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of adenosine triphosphate on the cardiovascular response to tracheal intubation.
    Mikawa K; Maekawa N; Kaetsu H; Goto R; Yaku H; Obara H
    Br J Anaesth; 1991 Oct; 67(4):410-5. PubMed ID: 1931397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deterioration of body oxygen metabolism by vasodilator and/or vasoconstrictor administration during cardiopulmonary bypass.
    Sato K; Sogawa M; Namura O; Hayashi J
    ASAIO J; 2006; 52(1):96-9. PubMed ID: 16436897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and optimal dose of intracoronary adenosine 5'-triphosphate for the measurement of coronary flow reserve.
    Sonoda S; Takeuchi M; Nakashima Y; Kuroiwa A
    Am Heart J; 1998 Apr; 135(4):621-7. PubMed ID: 9539477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine in myocardial protection in on-pump and off-pump cardiac surgery.
    Vinten-Johansen J; Zhao ZQ; Corvera JS; Morris CD; Budde JM; Thourani VH; Guyton RA
    Ann Thorac Surg; 2003 Feb; 75(2):S691-9. PubMed ID: 12607714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of the non-adenosine analogue A1 adenosine receptor agonist (BR-4935) on cardiovascular function after cardiopulmonary bypass.
    Veres G; Radovits T; Otila G; Hirschberg K; Haider H; Krieger N; Knoll A; Weigang E; Szabolcs Z; Karck M; Szabó G
    Thorac Cardiovasc Surg; 2010 Mar; 58(2):86-92. PubMed ID: 20333570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the conservative treatment of intermittent claudication].
    Brecht T; Hild R; Fux HD
    Munch Med Wochenschr; 1966 Dec; 108(48):2458-61. PubMed ID: 5340039
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension.
    Hachenberg T; Möllhoff T; Holst D; Hammel D; Brüssel T
    J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):453-7. PubMed ID: 9187994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium thiopental and mean arterial pressure during cardiopulmonary bypass.
    Dabbagh A; Rajaei S; Ahani MR
    Asian Cardiovasc Thorac Ann; 2011 Jun; 19(3-4):213-6. PubMed ID: 21885544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasodilator Agents in Pediatric Cardiac Surgery with Cardiopulmonary Bypass.
    Nicolau GO; Nigro Neto C; Bezerra FJL; Furlanetto G; Passos SC; Stahlschmidt A
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):412-422. PubMed ID: 29249581
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current therapeutic methods in refractory shock].
    Sumida S
    Geka Chiryo; 1970 Nov; 23(5):562-72. PubMed ID: 4926516
    [No Abstract]   [Full Text] [Related]  

  • 32. The efficacy and safety of a pharmacologic protocol for maintaining coronary artery bypass patients at a higher mean arterial pressure during cardiopulmonary bypass.
    Pirraglia PA; Peterson JC; Hartman GS; Yao FS; Thomas SJ; Charlson ME
    J Extra Corpor Technol; 1998 Jun; 30(2):64-72. PubMed ID: 10182115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine is a selective pulmonary vasodilator in cardiac surgical patients.
    Fullerton DA; Kirson LE; Jones SD; McIntyre RC
    Chest; 1996 Jan; 109(1):41-6. PubMed ID: 8549214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of milrinone on metabolism after cardiopulmonary bypass.
    Tatlis A; Papakonstantinou C; Toumbouras M; Gerolioliou K; Spanos P
    J Cardiovasc Surg (Torino); 2008 Feb; 49(1):113-8. PubMed ID: 18212696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stimulation of the visual function in glaucoma patients (clinico-experimental studies)].
    Bunin AIa; Iakovlev AA
    Vestn Oftalmol; 1968; 81(5):42-8. PubMed ID: 5737126
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of temperature and cardiopulmonary bypass on the pharmacokinetics of remifentanil.
    Russell D; Royston D; Rees PH; Gupta SK; Kenny GN
    Br J Anaesth; 1997 Oct; 79(4):456-9. PubMed ID: 9389262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels.
    Fortier S; DeMaria RG; Lamarche Y; Malo O; Denault A; Desjardins F; Carrier M; Perrault LP
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):109-16. PubMed ID: 15224029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study of the vasodilating action of Midocalm].
    Gereg P; Sporni L; Ezer E
    Farmakol Toksikol; 1967; 30(1):41-3. PubMed ID: 4874995
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous heparin for cardiopulmonary bypass is an acute vasodilator.
    Jacka MJ; Clark AG
    J Clin Anesth; 2002 May; 14(3):179-82. PubMed ID: 12031748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of nitric oxide for managing catastrophic pulmonary vasoconstriction arising from protamine administration.
    Ralley FE
    Anesth Analg; 1999 Mar; 88(3):505-7. PubMed ID: 10071995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.